Clinical Trials Browser

Phase 1/2 × UNKNOWN × titanium silicide × Clear all

NCT01542294 2016-06-14

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Phase 1/2 Unknown

Gastrointestinal

Stomach Neoplasms